| USDA Cracks Down on Synthetic Fatty Acids in Organic Milk The Obama administration, continuing its crackdown on the organic-food industry, is moving to eliminate synthetic fatty acids widely found in organic baby formula and organic milk. online.wsj.com |
Congressional Committee Finds J&J Uncooperative: Biotech's Latest Mishaps The Burrill Report submits: Johnson & Johnson (JNJ) has used delaying tactics in its dealings with a Congressional committee looking into the recent recall of children’s Tylenol and other pediatric medicines, the chairman of the committee told The New York Times. Rep. Edolphus Towns, D-New York and chair of the House Committee on Oversight and Government Reform, said in some instances the company has provided misinformation. J&J has denied these allegations. The newspaper said Congressional investigators may turn to subpoenas to force the company to cooperate. Already, the U.S. Food and Drug Administration, which is investigating violations in quality controls behind the recalls, is considering criminal penalties and other actions against McNeil Consumer Healthcare, the J&J unit that produced the drugs. The U.S. Food and Drug Administration has sent a 12-page warning letter to Pfizer (PFE) for failing to quickly notify the agency of serious and unexpected potential side effects from some of its top drugs including Viagra, Lipitor, Lyrica, Reuters reported. The delays date back to 2004 and have grown worse in recent years, the FDA said. The agency told Pfizer it had not properly documented or investigated reported problems in patients after the drugs were approved for use. The agency has requested a meeting with the company to discuss the violations.Complete Story » seekingalpha.com |
Eating to Live or Living to Eat? Seeing pictures of sweet and fatty foods can entice obese people to overeat, even when they're full, research in brain-imaging shows. online.wsj.com |
BioMarin Pipeline Update Zacks.com submits: Recently, BioMarin Pharmaceutical Inc.’s (BMRN) pipeline received a boost with the US Food and Drug Administration (FDA) granting orphan drug status to its candidate BMN-701, which is being developed to combat Pompe disease. The investigational new drug (IND) application for the candidate, which has been effective in pre-clinical studies, was accepted by the FDA with clinical trials expected to commence in the first quarter of 2011.Complete Story » seekingalpha.com |
ESF: New skills for older workers - Video If you’re seeking a strong human interest story, then take a look at the European Social Fund. Far from being a set of dry statistics, the ESF is the framework for thousands of fascinating tales of individual human endeavour. feedproxy.google.com |